SHR-A1811
Drug timelines are a Plus or Pro feature.
55 regulatory and trial events tracked for SHR-A1811, covering 2022-06-30 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]